MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hypokinesia"

  • 2022 International Congress

    Fatigue at different stages of parkinson’s disease

    A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

    Objective: study fatigue as a key non-motor symptom of parkinson's disease Background: Fatigue in PD refers to a state of fatigue, lack of energy, a…
  • 2022 International Congress

    Deep behavioural analysis of zebrafish models of Parkinson’s disease

    TM. Tzotzolaki, J. Garcia Fernandez, F. de Santis, J. Terriente (Barcelona, Spain)

    Objective: The objective is to characterise parkinsonian phenotypes in genetic and pharmacological models of Parkinson's disease (PD) using zebrafish. Background: Parkinson’s disease (PD) is a…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • MDS Virtual Congress 2021

    Neuroinflammation and Anti-Psychotic Drugs Induced Hyperkinesia or Dystonia in Treatment of Organic Brain Psychoses and Schizophrenia

    D. Labunskiy, S. Kiryukhina, V. Kolmykov, E. Govsh, D. Baranov, E. Razgadova (Saransk, Russian Federation)

    Objective: Our study goal was evaluation of neuroinflammatory processes in patients with psychoses received  anti-psychotic medications and developed hyperkinesia or dystonia symptoms. Evaluation of pro-inflammatory…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • MDS Virtual Congress 2021

    Accelerometry to optimize optical flow measurement of repetitive finger tapping movements: A pilot study

    K. Zumaeta, E. Torres, L. Urdiales, A. Ramirez, I. Camargo, B. Castaneda, S. Romero, K. Lizarraga (Lima, Peru)

    Objective: To optimize optical flow (OF) measurement of repetitive finger tapping movements with the use of concomitant accelerometry in healthy volunteers. Background: Repetitive finger tapping…
  • MDS Virtual Congress 2020

    A novel phasic and restricted basal ganglia thalamocortical subcircuitry model

    D. Kumbhare, G. Weistroffer, M. Baron (Richmond, VA, USA)

    Objective: To advance a novel basal ganglia thalamocortical (BGTC) model that accounts for GPi as a tonic-burst mode regulator of the thalamus and for restricted…
  • MDS Virtual Congress 2020

    Severity of Motor Symptoms in Parkinson’s Disease in Kazakhstan (on the example of the city of Almaty)

    A. Aralbayeva, S. Kamenova, A. Kondybaeva, K. Kuzhibaeva (Almaty, Kazakhstan)

    Objective: Determine the severity of motor symptoms with Parkinson's disease using the MDS-UPDRS scale. Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by…
  • 2019 International Congress

    Involuntary movements with abnormal brain imaging: A Case Report

    W. Webb, P. Chapman, V. Sung, M. Dean (Birmingham, AL, USA)

    Objective: To present a case of juvenile-onset Huntington's disease (HD) with a mixed phenotype and abnormal brain imaging. Background: HD is an autosomal-dominant neurodegenerative disorder…
  • 2019 International Congress

    Objective quantifiable assessment of nocturnal movements in patients with Parkinson’s disease using a wearable sensor

    A. Mirelman, I. Hillel, L. Rochester, A. Nieuwboer, B. Bloem, L. Avanzino, S. Shema-Shiratzki, I. Maidan, T. Herman, J. Cederbaum, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

    Objective: We aimed to explore the relationship between impaired bed mobility, disease severity, and other factors putatively related to NH. Background: Nocturnal hypokinesia (NH) is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley